Last reviewed · How we verify
Bone Therapeutics S.A — Portfolio Competitive Intelligence Brief
0 marketed
0 filed
1 Phase 3
1 Phase 2
1 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| JTA-004 | JTA-004 | phase 3 | Allogeneic cell therapy | Orthopedics / Bone Regeneration |
Therapeutic area mix
- Orthopedics · 1
- Orthopedics / Bone Regeneration · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Avicenna Research Institute · 1 shared drug class
- Biosolution Co., Ltd. · 1 shared drug class
- Brainstorm-Cell Therapeutics · 1 shared drug class
- Capricor Inc. · 1 shared drug class
- Celavie Bioscences, LLC · 1 shared drug class
- China Spinal Cord Injury Network · 1 shared drug class
- City of Hope Medical Center · 1 shared drug class
- Aivita Biomedical, Inc. · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Bone Therapeutics S.A:
- Bone Therapeutics S.A pipeline updates — RSS
- Bone Therapeutics S.A pipeline updates — Atom
- Bone Therapeutics S.A pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Bone Therapeutics S.A — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/bone-therapeutics-s-a. Accessed 2026-05-16.